Mr Purple podcast / Episode 126
Mr Purple podcast · Episode 126
Science Is Not a Conspiracy, with Gregory Austin
Evidence and belief often collide, and curious business leaders can learn from what happens next. Tom and Gregory Austin explore why science is not a conspiracy and how better questions help.
Prefer to listen? Also on Spotify and Apple Podcasts.
Subscribe on YouTubeWatch on YouTube
Show notes
Dr Tom Hitchcock, Mr Purple, explores why science is not a conspiracy with Gregory Austin, and what curious business leaders can learn when evidence, belief and better questions collide.
This is an archived CUSP Podcast recording, now shared as part of the Mr Purple collection.
Transcript (auto-generated, may contain errors)
Greg, we lost in Tom Hitchcock. How are you? I’m doing great, man. How are you doing, Tom? Not too bad. Open fire, I see in the background. It’s it’s a very convincing fake fire. It’s a little chilly here in Kansas City. We’ve had some cold snaps and I’m down in my home office in the downstairs, so it gets a little cooler. So it kind of makes a nice little bit of heat, little warm atmosphere as well. I like it. I like it. Well, that gave me the segue which I was hoping for to try and pinpoint the accent. Okay. So, Catastacy is where you are right now. What time is it there now? So it is 5.02 p.m. on Thursday. Yeah. How about you? What time is it for you and Sydney? 10 a.m. 10.02, obviously. All right. Not bad. Not bad. Okay.
It’s a good… I wasn’t sure if it was earlier than that. So this is not too early for you. It’s not bad. Now this is this is good timing and I could let you know what tomorrow’s like. I could say you know Friday’s any good Yeah, right that’s right. It is tomorrow there. I forget about that Yeah, so so you guys are coming into the what the end of your summer, right? And we’re getting to the end of our winter Just then to Dawson Yeah, so one one week into autumn We’ve got a cyclone here in Australia at the moment up in the Queensland not where I am But but the weather has had a bit of a turn here as well So I thought, do you know Australia well? I know about it. It’s on my bucket list, haven’t been.
I almost went when I was two years old actually. My dad had a job, he was a broadcaster in Brisbane. And they had it all set up and then the job and the place to live fell through just before they got on the plane. So they had to stay in the States. Otherwise I’d have a very similar accent probably. Well, I’m actually British with with a bit of an Australian swang now
So we’re not we’re the that’s if it wasn’t you broadcasting now from Kansas your dad would be broadcasting from Brisbane in the cyclone we just spoke about There you go Anyway, all right, we’re chewing the fat tell us a little bit about yourself. We’re going. What was it you do with your time?
Wow So I’m currently a business development director for a company called Solerion and we’re a phase one clinical conduct and bio analytical CRO contract research research organization. So we help Biotech and pharma companies get there, you know, really get their compounds off the ground and into the clinic on their way towards Hopefully registration and into therapies and helping people Okay, all right. So a lot of way you’ve bummed it down for an idiot like me at the end there. But let’s treat me like an idiot for the whole of this episode then. And you probably won’t be far from the truth. But let’s explain that so we can fully understand exactly what you do and what this means into our everyday lives.
Right. So I mean, all the all the medicines that that you take, whether it’s something simple as aspirin or ibuprofen or something more serious like a chemotherapy or other cancer treatments, they have to go through a very rigorous testing process. process and Before they can even be considered going on to the market and so what we do is we will help
Really? With a with a company who wants to get this in the clinic and train first of all just test. Hey, what’s the right dose? What’s what’s gonna? How is this gonna work? Is this enough to be effective and is it safe? And so we’ll recruit healthy volunteers into our clinic and they will you know for a fee They get paid pretty well actually to do that. There’s actually people who are career
subjects for clinical trials, believe it or not, and they just go from clinic to clinic doing this. And so they’ll take that and we’ll get that information. We’ll take it upstairs to our lab and then we’ll analyze what it’s doing in the body. Where it’s going in the body, how it’s distributing, how long it stays in the body. Is it effective? Is it causing any issues? And then that all gets reported to the FDA and they decide whether or not they can take it to the phase 2 and then phase 3 and then onto registration Okay, so it was something like that mark my my question is about the long-term effects Okay, so what’s the what’s your time frame? What’s the time frame where it’s actually where you it’s decided it’s safe for double market I I mean it can take years to go through the full process because it takes a lot of planning up front And you have to do recruiting you have to set up the clinic everything has to be done You know per FDA or if you’re doing it Europe EMA regulations so that you can keep track of All the data to make sure everything is actually real and safe and appropriate appropriate. Sometimes compounds die in phase one or phase two. Sometimes you make it all the way to phase three. The data looks good.
You finally get a big group of people. That’s when you have a large subset of individuals who have have whatever disease case it is. They go through and they do it and the data doesn’t turn out or it’s just not good enough to worth marketing. And so that’s why R&D is so expensive and that’s why drugs can be so expensive because it takes up to a billion dollars now to get a drug to registration and it can take about ten years. Wow, that’s that’s and it makes sense isn’t it? It’s as well as things you want to be safe with these things and you want to know how effective it is and the variables as well. How does how do your regulations compare to other countries? I would say the FDA and EMA are very very similar So there’s a lot of harmonization.
Health Canada isn’t very different. I don’t know is Australia health as well, but I’d say it’s fairly compatible because I know a lot of clinical trials are being done in Australia. And so it’s pretty compatible across most of the major countries. Okay. And your role with this, do you do the recruitment? Do you do the chemical side of it? Tell us a little bit more about your input. So, right. So, and I’m going to back up a little bit, tell you a little bit more about my story, kind of how I got into this.
Cause I started many years ago when I was in graduate school in developmental psychology and psychophysiology. And I fancied myself a professor and I thought this was going to be great. And I was really into it and I enjoyed the program, but I had a family young and realized that behavioral science doesn’t really pay. And I was going to spend a lot of money into getting a PhD and then not really be able to afford to pay that back or support a family. So I got into business, um, went into business intelligence, quickly got out of that, got into sales. So I sold in telecom and into, um, uh, data center sales. And then that market crashed after 9 11. And so I had a pivot, got out of business, looked into getting to the Air Force and their OTC program as an officer. And I was two inches away from launching my career in the Air Force when the entire branch decided that if you’re not a computer science major and if you’re not an engineer, you’re out.
So I was out and I’m like, okay, and I got a punt again. Now what do I do? And I had a friend who was in the FBI and law enforcement and he convinced me that’d be a pretty cool career. So I looked into that. Stepping stone would be to become a police officer first. So I did that. I was a street cop and Savannah, Georgia in the dirty South for three years chasing bad guys and
Got out of that moved to Maryland was hired in marketing with a real estate brokerage And then the real estate market crashed I mean you could kind of predict what industry what industry was gonna tank because that was the one I was in So then we kind of get into where I got into the the biotech industry My dad got sick. He had melanoma many years before was fine for 17 years and all of a sudden had a brain tumor And it was operable. It’s kind of right here. They able to get it out The tumor was probably about golf ball size, but there’s a huge hematoma around it So it was quite a bit of pressure that he was experiencing Successful surgery was doing great. I actually moved in to help my mom She was all about you know five foot and a buck ten and needed help You know just kind of taking care of him as he recovered so I was happy to be in a place in my life I could do that and so I’m helping him. I’m kind of bored He’s doing well and so I ended up finding a guy who ran a recruiting agency and that’s how I got into recruiting He taught me everything I knew about Agency recruiting and how to recruit how to find good clients and so forth Tom Scholl great guy and and I Decided to get into biotech Pharma science because selfishly I wanted to find some clinical trials for my dad. And well, I did find some, some neuroscientists, unfortunately, especially at that time, I mean, this is 17 years ago, there was really nothing anyone could do was just a death sentence. And it was just a matter of time, unfortunately. But that’s how I launched my career into that. I did that for about two or three years. And then we had another economic correction, ended up working for a nonprofit called the Boston Society and basically put on scientific symposia for three years. And that’s why I got to meet tons of these great scientific leaders. And what I loved about that part of the industry, because I’ve been in business, you know how it is, it’s cutthroat, it’s competitive, it’s intense, but you would have people that are with Merck or with Pfizer with BMS or with GSK. And you would know you think they’re on the same company because they’re very collegial. They’re all trying to work together to make drugs safe and effective and because they want drugs that you can take and their kids can take and their parents can take and In fact, there’s some cases. I know people that they’re they have family members on the very drugs They helped get to market which is kind of wild So I did that as a nonprofit. It was time to move on and make some more money I got back into recruiting did recruiting for about nine years. I wrote a book It’s the resume writing secrets from a corporate recruiter and I self published that on Amazon, which was a lot of just something I wanted to do man. It was a lot of fun went through that process and stayed in recruiting for a little while got back into the form of biotech industry and consulting and recruited there and then I pivoted into sales. So I sold consulting services for a couple of companies. And then I started a podcast called Bio Talk Unzipped.
And it’s just something I wanted to do, man. I love talking to people. I love the science. And I asked my first guest, Chad Briscoe, I said, Hey, will you be on the show? This is what I’m trying to do. He was like, Yeah, I would love to. I enjoy that. He goes, Greg, let me tell you something. I’ve done this kind of thing before. How would you feel about a co-host? And it was an easy decision. I’ve known Chad for years. guy. And now we partner as co-hosts on this show. We’ve done it for a little over a year, and we bring on scientific innovators and leaders and technology guys and just great people in the industry that have an interesting story to tell, just kind of unzipping those stories behind medical progress.
And the feel is kind of like this, you know, we’re like, we’re having a conversation over over a beer at a pub and talking about science, okay? That’s kind of the feel of it. And I just did it because I wanted to do something different. I want to be looked at as a thought leader, not as a sales guy, someone who’s going, who’s in the know and who wants to help make this industry better and make people’s lives better. And then Chad kind of got me into what he was doing over at Solerion, brought me in, and that’s where I am today. Yeah, okay. I do like your gentle nod to if it’s a sector that’s going to crash, you’re probably going to work in it. that that That was quite an interesting story. So you’ll know as well as I do when you put your, your recruiter hat on and you listen to someone’s career background, it’s fascinating.
It says a lot about the person’s circumstances and their wine and how they operate. Your story alone is probably worth two or three other people’s full career. Because there’s all sorts in there, from public to private, and what have you. And essentially pools of so many different attributes,
that there’s very much left brain, right brain, industries in there, we put them this strength and that strength. I think knowing, take the economy and circumstance out of the equation and your history with these sectors, which one of them best suited your skill set? That’s a great question because I have done a variety of things. I would have to say these more complex consultative sales is where I shine the most because I still get to know people, get to use some of my recruiting background in terms of being curious, asking good questions. I also love the science and I get the opportunity being in this role to hear about what’s groundbreaking, what’s coming out, what’s brand new and helping hopefully get that to market or bring that to light.
And so that’s where I, plus I get to do some of these other things like podcasting and writing that I enjoy. And that’s where I see my retirement quite frankly. I don’t intend to fully ever retire. I may stop working for, you know, the man, if you will, and working for a company and just continue podcasting, speaking, writing books and just helping people where I can.
Okay, I love it. Okay. All right. And do you think the, maybe the PhD, the professor title, might resurface now things that have been settled for you? I would love to do that. I don’t think it’s realistic because I know how intense and how hard it is to be in that program. I lived it. I think my last semester at the University of Florida probably averaged about two, three hours a night because I was in the middle of a research program. I was teaching for the first time. I was taking classes. It was very intense. I could do that in my 20s. I couldn’t do that in my mid 50s. It would take me 10, 20 years just to get the PhD probably at that, at the pace that I could do it. If I could do it full time, I could probably hang in there, but I would love to do that, but I don’t think it’s probably gonna happen.
Okay, and your podcast is still happening now? Yeah, yeah, we’ve been doing it. We got through our first year, we’re in season two, and just continue to go strong. And we’ve done a couple of on location sites now, and we’re going to do a third one, probably sometime in the next quarter or so in New Jersey to highlight Steam Park, which is a really cool nonprofit in Philly that really helps kids, especially kids who don’t have as much access to get education, to get them those STEM opportunities in science and engineering and technology and it’s really cool to see those kids really get excited about learning those things. Good well feel free to promote your podcast through this as well.
You’re more than welcome to. Okay and I’ve got a bit of a sort of off-center question for you then and I’m not sure if it’s actually nerve or not but you know what to give it a go. the the right Okay How’s everything being received that has the effect of that happening in the states?
It mixed you know, I think it’s for most people it’s either love or hate I Think the hardest thing for people to swallow is seeing someone who was not elected with so much power and influence over our government and So so what Elon Musk is doing, you know there to be honest there’s some there’s some probably fat that needed to be cut, you know, there’s I think there was probably a lot of waste in governments. And so I I get that is just his methodology is pretty crazy. It’s like people are not people. They’re just a commodity. And whatever you don’t matter if you don’t work 20 hours a day, your shit to me, you know, it’s kind of the the feel to it. And so that doesn’t rest well with a lot of people, but it’s not all, it’s not necessarily all bad.
We’ll see how it fleshes out. You know, it’s been in my industry, we haven’t felt it yet in terms of how it’s affecting the FDA. Is it going to take longer to get drugs approved? Because there’s less people to review that we just don’t know yet. So we’ll see how that effects. What concerns me the most is what’s happened with the NIH, the National Institute of Health. I’ve worked with them in the past. They’re an amazing organization. There’s really wonderful dedicated people. And their mission is just, this is for them, their funding research no one else can fund, right? You have a, let’s say you’re in academia and you have this remarkable cancer fighting agent, but you have no money. You don’t have access to get the fundraising.
you could work potentially with the NIH if you’re doing things right and they could fund that research, bring clinical trials into their hospital there in DC and run that. And for some people, if you listen to those stories, that’s their last chance. You know, they’re dying and they’re willing to take a chance on whatever experimental drug they can get their hands on. And so I hope that doesn’t alter their mission or slow things down for them. So it’s hard to know because I’m not in each one of those to see how that is going to affect. I’m really curious because I’ve heard, you know, some things, some responses from Europe and I know some of the Europeans are like, well, I don’t know what’s going on over there. I don’t know if we want to send samples over to the US. I mean, we just, things are kind of sketchy. What is your perspective? Not that you speak for an entire country, but you know, How is it being received in Australia? So it’s interesting because I think I would imagine or presume it’d be the same in the states where there’s two sets of media Okay, spinning two sets of narratives. Okay and there is a bit of a mainstream and then there’s and then there’s the other side as well and and Yeah, I don’t know perhaps I’m a dabbler, my son’s 10 years old and I teach him to question everything.
Just don’t take something as gospel. The same spirit as a scientist. You’ve got theory, put it to test, see how robust it is. You might be wrong, you might be right. We don’t know until we do something but question and experiment. Which means if you go and make mainstream news, this is a really good example of that. Let’s question everything, let’s not just take that as is. So if the Europeans saying this, okay, let’s have a little look at this and let’s lift the bonnet up a bit so I Do feel there’s quite a distinct narrative Against him because he’s quite easy to pick on How he carries himself and what have you?
But I do see a lot of good happening as well, okay, and I think I think he’s breaking down some summer sort of more conventional things that are not necessarily serving in your case the states and it seems to be a lot more focused on states now and keeping things insular than being the world police for once better terminology, okay? Right. Which is probably a good thing for the states but obviously in the grand scheme, things maybe not. So I feel we’re getting a similar narrative to you guys are. It depends. It’s almost like your opinion is shaped and what channel you’ve you tune into.
Right. It is. And it’s hard for me. And I think there’s a lot of Americans who maybe feel this way. I’m about as moderate as they come. You know, I see pros and cons on the left. I see pros and cons on the right. I don’t think any side is particularly right or wrong. There’s just some policies are good. Some policies aren’t so good. Some positive changes. We needed more security at our borders. The last administration really failed in that area, very clearly failed. So I like seeing some of that. I don’t necessarily agree with some of the hard-line policies of how they’re going about it. It’s like, oh, you’re born here, but your parents weren’t. Well, you may not be able to stay. Well, that’s okay. Good luck with that. That’s kind of a, that’s been a thing for a long time. And I don’t know legally how you You can change that, but there’s a lot of that going on.
Same thing with the FDA. I’ve gotten to meet a number of reviewers and investigators and high-level people at the FDA, not high, high-level, but people who are in management, great people. They really care about public health. They’re not trying to make things difficult for industry to get things done, but they’re committed to making it safe. And if you can work with them, they’ll work with you. And then it usually works out OK if you have good data and it works, right? So what I don’t understand on the other side of things, outside of pharma, on the food side, it boggles my mind where most of the world will cut out things, all these chemicals in the red forties and the causes cancer. It’s okay in America.
We’re feeding this to our kids. Every candy has red 40. And it’s like, eh, it’s okay. And so RFK Jr. And I hope he does something about this to be honest because that’s one thing I really agree with. We should not, there’s a lot of things that should be banned from our food supply. And it’s really scary that it’s in there, quite frankly. And we don’t know how much problems it’s causing people, whether it’s cancer or other disease conditions. But he’s, you know, boy, that guy’s in the French. I don’t know about him, but I hope he can fix at least that part of it and catch up with the rest of the world who’s like, oh, you know, we’re going to use natural coloring instead of these chemicals that we don’t know what they’ll do to you.
It is fascinating because obviously America is famous for having some very questionable components in in the in the food and and It really does make you wonder, but when we you see old adverts where there’s arsenic in this and there’s cocaine in that
Anything goes is it make money great we’ll take it It’s comical we can laugh at it now, but we’re still in that state. We go 50 years ahead They’ll be laughing up. We were still pretty nice to our kids and ourselves obviously It’s we don’t think we have truly evolved to learn that lesson yet Right, right and and I hope that we can keep going back to the science the science the science You know one of the first things, you know, I did in my podcast I actually interviewed Chad and just asked him a bunch of questions. Then we started bringing on guests. And one of the things I asked him is what, you know, what surprised you the most? And he’s like, you know, one was all the bad decisions people make in biotech.
When it seems pretty clear what the right answer is, but it’s also, he was disappointed in how science has got politicized, especially during COVID. And it’s like, you just, people don’t realize how hard these scientists work and how much they care. And to call them a conspiracy is just laughable to us. And so I coined the phrase, like, science is not a conspiracy. It’s like, it’s not. It’s science, you know? And if it’s a conspiracy, it’s not science. You know, it’s very factual and straightforward. You can test it or you can’t. And it’s, yeah. So I hope we stay away from politicizing that and just stick to what we know. That’s a very fair point as well, isn’t it? Because obviously people use the term science in their marketing quite a bit.
Backed by science, this is based on science, etc, etc, etc. And it’s a point of reference for validity, if you like, and quality. But if we politicize things, if you’re quite right, which is there, then we’re doing it in justice, that’s for sure. Okay, before we wrap up, thanks for coming to a close now. So on this interview, they want to get in contact with you on a bit more and want to engage you in some capacity. What would be the best way for them to reach out to you, Gregory? LinkedIn is the number one way to get a hold of me. And that’ll be, you can just look me up, Gregory Austin. And I’ve got a pretty decent following. So hopefully I’ll pop up somewhere in there. somewhere in there, but yeah, just send me a, and please, when you send me a contact request or an invite, tell me a little bit of something about yourself and why I get so many.
You know, LinkedIn used to be a great platform. I still like it a lot. I don’t love it as much as I used to because it’s just being overused and overrun by people just spamming, spamming, and now AI bots. And you know, you, you, LinkedIn, connect with somebody you think is going to be, you know, someone nice to know. And then before you even get to say hi, they’re already pitching you something. And nobody likes that. And yet it happens constantly. So now I’m really careful about who I connect with because I want to waste my time with that sort of silliness. Yeah, I agree with what we all receive at the end of them. I think that the role with that is, you know, what would you think if you received that same interaction yourself, you know, so if it is that instantaneous message, you You simply can’t type that quick.
Yeah, right. And it’s not personal, clearly out of context. And how would that make you feel? Well, I ignore it. I archive it. I’m a reconnect. It’s talking about first impressions, then it’s not the right thing to be doing. Absolutely. And that brings me to a couple of parting thoughts I would like to leave with your audience. And that’s when it comes to, you know, the use of something like a LinkedIn or even in-person networking. And I don’t even know if I want to call it networking anymore because sometimes networking gets a bad, right? A bad rap because it’s like, oh, I’m trying to use you to get to somewhere to get to a job or get to somebody else. And it’s really, it’s about relationship building.
You know, build, you know, build your circle, build whatever you call it, your community of relationships. And look to see what you can do for them. before you even think about what you want, you know, when asking something. And it’s something I’ve been talking about for a long time and then I came across the book, never alone and really validated what I’ve been saying because that’s exactly the tone of the book and I don’t know if you’ve ever seen it but it’s brilliant in that area. It’s all about having fun, having real authentic relationships and just doing something out of the kindness your heart to help people and good things always come about. So never stop building those relationships.
Good things will come to you. Well, wonderful way to sign off an episode, brilliant. Thank you very much, Greg. And I’m sure we’ll speak again soon. Sounds good. My pleasure. Thanks for having me, Tom.
Related from Mr Purple
Mistakeology: The systematic study of mistakes: using them as useful data rather than ammunition.
Want to talk about your own business?
Book 15 minutes with Tom. No pitch, just a useful conversation.
Book 15 with Tom